PARSONS C LOWELL has a total of 24 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, Singapore and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and medical technology are APBI HOLDINGS LLC, TRADITIONAL CHINESE MEDICINE I and BIOLOG I I SISTEMY AOZT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Singapore | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Australia | 1 | |
#9 | Hungary | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Syringes | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Parsons C Lowell | 22 |
#2 | Goldberg Michael M | 1 |
#3 | Goldberg Michael | 1 |
#4 | Meenan Christopher P | 1 |
#5 | Parsons C | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021011566A1 | Alkalization of urinary bladder wall prior to treatment with intravesical heparin and alkalinized lidocaine to enhance relief of bladder pain symptoms | |
SG10201402682RA | Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer | |
US2013150323A1 | Use of oral heparin preparations to treat urinary tract diseases and conditions | |
US2009023637A1 | Methods for detecting and treating interstitial cystitis |